This map shows the geographic impact of A. Barbeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Barbeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Barbeau more than expected).
This network shows the impact of papers produced by A. Barbeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Barbeau. The network helps show where A. Barbeau may publish in the future.
Co-authorship network of co-authors of A. Barbeau
This figure shows the co-authorship network connecting the top 25 collaborators of A. Barbeau.
A scholar is included among the top collaborators of A. Barbeau based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with A. Barbeau. A. Barbeau is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Gonce, M & A. Barbeau. (2023). CURRENT TREATMENT ON PARKINSON'S DISEASE. International Research Journal of Modernization in Engineering Technology and Science. 31(19). 563–73.
2.
Keats, Bronya J.B., Mei Lü, Cynthia Forster‐Gibson, et al.. (1987). Linkage studies of Friedreich ataxia by means of blood-group and protein markers. PubMed Central.2 indexed citations
Barbeau, A., et al.. (1979). Investigation of the relationship between some brain peptides and neurotransmitters.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 13(1-4). 157–65.1 indexed citations
6.
Steinberg, Malcolm S., et al.. (1979). Hemagglutination by Lectins in Friedreich's Ataxia. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 6(2). 299–309.1 indexed citations
Gonce, M & A. Barbeau. (1978). [Physiological trials with MIF-I in Parkinson's disease (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 134(2). 141–9.3 indexed citations
11.
Melançon, S., Louis Dallaire, Guillaume Fontaine, et al.. (1978). Lipoamide Dehydrogenase in Friedreich's Ataxia Fibroblasts. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 5(1). 115–118.12 indexed citations
Barbeau, A., Marie-Claude Roy, & Abba J. Kastin. (1976). Double-blind evaluation of oral L-prolyl-Lleucyl-glycine amide in Parkinson's disease.. VocBench (University of Rome Tor Vergata). 114(2). 120–2.42 indexed citations
14.
Barbeau, A.. (1976). Recent developments in Parkinson's disease and Huntington's chorea.. PubMed. 11(1). 17–27.7 indexed citations
15.
Barbeau, A.. (1974). High-level levodopa therapy in Parkinson's disease: five years later.. PubMed. 99. 160–3.13 indexed citations
16.
Barbeau, A.. (1970). Biochimie et traitement de la maladie de Parkinson.. 41(7).1 indexed citations
17.
Barbeau, A.. (1967). The "pink spot", 3,4-dimethoxyphenylethylamine and dopamine. Relationship to Parkinson's disease and to schizophrenia.. PubMed. 26(1). 55–79.10 indexed citations
18.
Barbeau, A., et al.. (1964). [HUNTINGTON'S CHOREA IN FRENCH CANADIANS. PRELIMINARY STUDY].. PubMed. 93. 1178–82.8 indexed citations
19.
Barbeau, A., et al.. (1961). Some biochemical aspects of extrapyramidal diseases.. PubMed. 20. 197–203.8 indexed citations
20.
Barbeau, A., et al.. (1961). [Clinical experience with tolbutamide in Parkinson's disease].. PubMed. 90. 147–51.14 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.